![Adam Logal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 900 327 $ al 31/05/2026
Adam E.
Logal is currently Director at Bio-Reference Laboratories, Inc. since 2015, Director at OPKO Biologics Ltd. since 2014, Director at Non-Invasive Monitoring Systems, Inc. starting 2025, and CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. since 2021.
Former positions include Chairman at Xenetic Biosciences, Inc. from 2017 to 2024, Finance Director, Secretary, Treasurer & CAO at eXegenics, Inc. in 2007, Independent Director at VBI Vaccines, Inc. from 2014 to 2018, Director at SciVac Therapeutics, Inc., Chief Financial & Accounting Officer at Nabi Biopharmaceuticals from 2002 to 2007, and President at GeneDx LLC from 2020 to 2021.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OPKO HEALTH, INC. 0,08 % | 27/05/2025 | 616.662 ( 0,08 % ) | 900 327 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OPKO HEALTH, INC. | Director Financiero/CFO | 31/03/2014 |
| BIO-REFERENCE LABORATORIES INC | Director/Miembro de la Junta | 20/08/2015 |
| NON-INVASIVE MONITORING SYSTEMS, INC. | Director/Miembro de la Junta | 03/09/2025 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Director/Miembro de la Junta | 01/04/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Presidente | 11/12/2024 |
GeneDx LLC
 GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Presidente | 01/06/2021 |
| VBI VACCINES INC. | Director/Miembro de la Junta | 01/10/2018 |
eXegenics, Inc.
 eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director Financiero/CFO | 13/06/2007 |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Director Financiero/CFO | 01/01/2007 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Bio-Reference Laboratories, Inc.
 Bio-Reference Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing services | Commercial Services |
Non-Invasive Monitoring Systems, Inc.
 Non-Invasive Monitoring Systems, Inc. Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
eXegenics, Inc.
eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
OPKO Health, Inc.
 OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
SciVac Therapeutics, Inc.
 SciVac Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
